162 related articles for article (PubMed ID: 27697093)
1. Knockdown of DDX46 Inhibits the Invasion and Tumorigenesis in Osteosarcoma Cells.
Jiang F; Zhang D; Li G; Wang X
Oncol Res; 2017 Mar; 25(3):417-425. PubMed ID: 27697093
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of DDX46 suppresses the proliferation and invasion of gastric cancer through inactivating Akt/GSK-3β/β-catenin pathway.
Chen L; Xu M; Zhong W; Hu Y; Wang G
Exp Cell Res; 2021 Feb; 399(1):112448. PubMed ID: 33347858
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of DDX46 inhibits proliferation and induces apoptosis in esophageal squamous cell carcinoma cells.
Li B; Li YM; He WT; Chen H; Zhu HW; Liu T; Zhang JH; Song TN; Zhou YL
Oncol Rep; 2016 Jul; 36(1):223-30. PubMed ID: 27176873
[TBL] [Abstract][Full Text] [Related]
4. The role of DDX46 in breast cancer proliferation and invasiveness: A potential therapeutic target.
Ma Z; Song J; Hua Y; Wang Y; Cao W; Wang H; Hou L
Cell Biol Int; 2023 Jan; 47(1):283-291. PubMed ID: 36200534
[TBL] [Abstract][Full Text] [Related]
5. GREM1 overexpression inhibits proliferation, migration and angiogenesis of osteosarcoma.
Gu Q; Luo Y; Chen C; Jiang D; Huang Q; Wang X
Exp Cell Res; 2019 Nov; 384(1):111619. PubMed ID: 31525341
[TBL] [Abstract][Full Text] [Related]
6. The effect of DNA-PKcs gene silencing on proliferation, migration, invasion and apoptosis, and in vivo tumorigenicity of human osteosarcoma MG-63 cells.
Jin PY; Lu HJ; Tang Y; Fan SH; Zhang ZF; Wang Y; Li XN; Wu DM; Lu J; Zheng YL
Biomed Pharmacother; 2017 Dec; 96():1324-1334. PubMed ID: 29203385
[TBL] [Abstract][Full Text] [Related]
7. DDX46 silencing inhibits cell proliferation by activating apoptosis and autophagy in cutaneous squamous cell carcinoma.
Lin Q; Jin HJ; Zhang D; Gao L
Mol Med Rep; 2020 Nov; 22(5):4236-4242. PubMed ID: 33000271
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of TBRG4 suppresses proliferation, invasion and promotes apoptosis of osteosarcoma cells by downregulating TGF-β1 expression and PI3K/AKT signaling pathway.
Huang F; Zhou P; Wang Z; Zhang XL; Liao FX; Hu Y; Chang J
Arch Biochem Biophys; 2020 Jun; 686():108351. PubMed ID: 32240636
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of pyruvate kinase type M2 suppresses tumor survival and invasion in osteosarcoma cells both in vitro and in vivo.
Yuan Q; Yu H; Chen J; Song X; Sun L
Exp Cell Res; 2018 Jan; 362(1):209-216. PubMed ID: 29155364
[TBL] [Abstract][Full Text] [Related]
10. SIX1 reduces the expression of PTEN via activating PI3K/AKT signal to promote cell proliferation and tumorigenesis in osteosarcoma.
Yu C; Zhang B; Li YL; Yu XR
Biomed Pharmacother; 2018 Sep; 105():10-17. PubMed ID: 29807230
[TBL] [Abstract][Full Text] [Related]
11. Lentiviral DDX46 knockdown inhibits growth and induces apoptosis in human colorectal cancer cells.
Li M; Ma Y; Huang P; Du A; Yang X; Zhang S; Xing C; Liu F; Cao J
Gene; 2015 Apr; 560(2):237-44. PubMed ID: 25680556
[TBL] [Abstract][Full Text] [Related]
12. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
Zhang Y; Cheng H; Li W; Wu H; Yang Y
Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA DLEU1 aggravates osteosarcoma carcinogenesis via regulating the miR-671-5p/DDX5 axis.
Chen X; Zhang C; Wang X
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3322-3328. PubMed ID: 31379208
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
15. TRIM66 overexpresssion contributes to osteosarcoma carcinogenesis and indicates poor survival outcome.
Chen Y; Guo Y; Yang H; Shi G; Xu G; Shi J; Yin N; Chen D
Oncotarget; 2015 Sep; 6(27):23708-19. PubMed ID: 26247633
[TBL] [Abstract][Full Text] [Related]
16. APLNR promotes the progression of osteosarcoma by stimulating cell proliferation and invasion.
Cui L; Zhang JY; Ren ZP; Zhao HJ; Li GS
Anticancer Drugs; 2019 Oct; 30(9):940-947. PubMed ID: 30920988
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor-1 promotes cancer progression through activating AKT/Cyclin D1 signaling pathway in osteosarcoma.
Zhang B; Li YL; Zhao JL; Zhen O; Yu C; Yang BH; Yu XR
Biomed Pharmacother; 2018 Sep; 105():1-9. PubMed ID: 29807229
[TBL] [Abstract][Full Text] [Related]
18. Silencing Transmembrane Protein 45B (TNEM45B) Inhibits Proliferation, Invasion, and Tumorigenesis in Osteosarcoma Cells.
Li Y; Guo W; Liu S; Zhang B; Yu BB; Yang B; Kan SL; Feng SQ
Oncol Res; 2017 Jul; 25(6):1021-1026. PubMed ID: 28244852
[TBL] [Abstract][Full Text] [Related]
19. The tetraspanin CD81 mediates the growth and metastases of human osteosarcoma.
Mizoshiri N; Shirai T; Terauchi R; Tsuchida S; Mori Y; Hayashi D; Kishida T; Arai Y; Mazda O; Nakanishi T; Kubo T
Cell Oncol (Dordr); 2019 Dec; 42(6):861-871. PubMed ID: 31494861
[TBL] [Abstract][Full Text] [Related]
20. TRIM2 regulates the development and metastasis of tumorous cells of osteosarcoma.
Qin Y; Ye J; Zhao F; Hu S; Wang S
Int J Oncol; 2018 Oct; 53(4):1643-1656. PubMed ID: 30066883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]